Dr. Villalona is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Medical Oncology and Therapeutics Research
1500 East Duarte Road
Duarte, CA 91010Phone+1 626-256-4673Fax+1 626-218-8233- Is this information wrong?
Education & Training
- University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Hematology and Medical Oncology, 1994 - 1995
- University at BuffaloFellowship, Hematology and Medical Oncology, 1990 - 1992
- University of MinnesotaFellowship, Hematology and Medical Oncology, 1989 - 1990
- SUNY Health Science Center at BrooklynResidency, Internal Medicine, 1986 - 1989
- Universidad Nacional Pedro Henriquez UrenaClass of 1985
Certifications & Licensure
- FL State Medical License 1998 - 2025
- CA State Medical License 2020 - 2024
- KY State Medical License 2020 - 2021
- OH State Medical License 1999 - 2017
- TX State Medical License 1995 - 2010
- AL State Medical License Active through 1996
- MN State Medical License 1989 - 1994
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Fellow American Association for the Advancement of Science
- Fellow American College of Physicians
- Premio Fray Anton de Montesinos Asociacion de egresados UASD NYC
- Join now to see all
Clinical Trials
- Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Esophageal and Stomach Cancer Start of enrollment: 2001 Sep 01
- Phase I & Biological Study of Etanercept & Weekly Docetaxel in Patients With Advanced Solid Tumors Start of enrollment: 2000 Nov 01
- Etanercept and Gemcitabine in Patients With Advanced, Chemotherapy Naive Pancreatic Adenocarcinoma Start of enrollment: 2001 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- Preclinical Evaluation of Off-The-Shelf PD-L1+ Human Natural Killer Cells Secreting IL15 to Treat Non-Small Cell Lung Cancer.Ting Lu, Rui Ma, Anthony G Mansour, Christian Bustillos, Zhiyao Li, Zhenlong Li, Shoubao Ma, Kun-Yu Teng, Hanyu Chen, Jianying Zhang, Michael A Caligiuri, Jianhua Yu, ...> ;Cancer Immunology Research. 2024 Apr 3
- 1 citationsA phase II study of bevacizumab and temsirolimus in advanced extra-pancreatic neuroendocrine tumors.Sonia M Abuzakhm, Vineeth Sukrithan, Briant Fruth, Rui Qin, Jonathan Strosberg, Timothy J Hobday, Thomas Semrad, Diane Reidy-Lagunes, Hedy Lee Kindler, George P Kim, J...> ;Endocrine-Related Cancer. 2023 Nov 1
- Targeted Therapies in Early-Stage Resectable Non-Small-Cell Lung Cancer: New Kids on the Block.Jason Liu, Arya Amini, Ameish Govindarajan, Tariq Abuali, Isa Mambetsariev, Erminia Massarelli, Victoria Villaflor, Miguel Villalona-Calero, Howard West, Terence Willi...> ;JCO Precision Oncology. 2023 Sep 1
- Join now to see all
Press Mentions
- New Advances in Treating Lung Cancer, the Deadliest CancerMay 20th, 2016
Grant Support
- Targeting Somatic Homologous Recombination In Solid TumorsNational Cancer Institute2010–2012
- Early Therapeutics Development With Phase II EmphasisNational Cancer Institute2011
- Early Therapeutics Development With Phase II EmphasisNational Cancer Institute2010
- Tas:: 75 0850 ::Tas Recovery ACT - Actnow Clinical Trial 8472Division Of Cancer Treatment2009
- Early Therapeutics Development With Phase II EmphasisDivision Of Cancer Treatment2009
- Biomodulation Of Capecitabine By Docetaxel In Non-Small*National Cancer Institute2004–2005
- TNF Blockade In Pancreatic Cancer PatientsNational Cancer Institute2003–2004
- Phase II Randomized Trial Of CPT-11 And Mitomycin CNational Cancer Institute2002–2003
- Phase I Study Of Sequential CPT 11 &Mitomycin CNational Center For Research Resources1999–2002
- Translational Research In Lung CancerNational Cancer Institute1998–2002
- Phase I Study To Determine The Safety Of Ecteinascidin-743National Center For Research Resources1997–2000
- Phase I Protocol To Determine The Safety Of Lu79553 As An IV Infusion Daily X 5National Center For Research Resources1998–1999
- Phase I Trial Of PN401 As Rescue Agent For Escalating Doses Of 5-FUNational Center For Research Resources1997–1999
- Translational Research In Lung CancerNational Cancer Institute1997–1998
- Phase I Protocolto Determine The Safety Of Lu79553 As An IV Infusion Daily X 5National Center For Research Resources1997
- Effect Of H Corticotropin Releasing Factor On Peritumoral BrainNational Center For Research Resources1996
Other Languages
- Spanish
Hospital Affiliations
- City of Hope Comprehensive Cancer CenterDuarte, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: